RetinalGenix Technologies (RTGN) Research & Development (2020 - 2026)
RetinalGenix Technologies (RTGN) posted Research & Development of $117064.0 for Q1 2026, up 235.02% sequentially from $34942.0 in Q4 2025, and up 785.91% YoY from $13214.0 in Q1 2025.
RetinalGenix Technologies (RTGN) Research & Development (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Research & Development for 7 years, with the latest figure at $117064.0 in Q1 2026.
- Quarterly Research & Development rose 785.91% year-over-year to $117064.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186890.0 (down 38.4% YoY) and the FY2025 annual result came in at $83040.0, down 77.75% from the prior year.
- Research & Development improved to $117064.0 in Q1 2026 per RTGN's latest filing, from $34942.0 in the prior quarter.
- Over five years, Research & Development peaked at $317819.0 in Q4 2022 and troughed at $13214.0 in Q1 2025.
- A 5-year average of $112165.5 and a median of $102977.0 in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2025 and 2026: Research & Development sank 84.1% in 2025, then jumped 785.91% in 2026.
- Over 5 years, Research & Development stood at $317819.0 in 2022, then plunged by 83.04% to $53896.0 in 2023, then soared by 93.47% to $104271.0 in 2024, then slumped by 66.49% to $34942.0 in 2025, then surged by 235.02% to $117064.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $117064.0, $34942.0, and $20454.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 28.60 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 117,064.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117,064.00 |
| Dec 31, 2025 | 34,942.00 |
| Sep 30, 2025 | 20,454.00 |
| Jun 30, 2025 | 14,430.00 |
| Mar 31, 2025 | 13,214.00 |
| Dec 31, 2024 | 104,271.00 |
| Sep 30, 2024 | 102,977.00 |
| Jun 30, 2024 | 82,926.00 |
| Mar 31, 2024 | 83,097.00 |
| Dec 31, 2023 | 53,896.00 |
| Sep 30, 2023 | 89,778.00 |
| Jun 30, 2023 | 152,577.00 |
| Mar 31, 2023 | 227,932.00 |
| Dec 31, 2022 | 317,819.00 |
| Sep 30, 2022 | 198,504.00 |
| Jun 30, 2022 | 135,439.00 |
| Mar 31, 2022 | 157,493.00 |
| Dec 31, 2021 | 182,244.00 |
| Sep 30, 2021 | 200,899.00 |
| Jun 30, 2021 | 159,941.00 |